Tilray Brands, Inc. (2HQ.DE)
EUR 1.16
(0.43%)
EUR 1.16
(0.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 387.31 Million USD | -34.37% |
| 2022 | 590.13 Million USD | -5.4% |
| 2021 | 623.8 Million USD | -33.54% |
| 2020 | 938.65 Million USD | 212.55% |
| 2019 | 300.32 Million CAD | -16.84% |
| 2018 | 361.11 Million CAD | 1397.9% |
| 2017 | 24.1 Million CAD | -2.84% |
| 2016 | 24.81 Million CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 322.12 Million USD | -4.65% |
| 2023 Q3 | 481.61 Million USD | -9.02% |
| 2023 Q4 | 387.31 Million USD | -19.58% |
| 2023 FY | 387.31 Million USD | -34.37% |
| 2023 Q1 | 562.71 Million USD | -4.65% |
| 2023 Q2 | 529.38 Million USD | -5.92% |
| 2022 Q3 | 603.73 Million USD | -0.85% |
| 2022 Q1 | 657.81 Million USD | 5.45% |
| 2022 FY | 590.13 Million USD | -5.4% |
| 2022 Q4 | 590.13 Million USD | -2.25% |
| 2022 Q2 | 608.91 Million USD | -7.43% |
| 2021 Q3 | 732.87 Million USD | -8.37% |
| 2021 Q1 | 873.73 Million USD | -6.92% |
| 2021 FY | 623.8 Million USD | -33.54% |
| 2021 Q4 | 623.8 Million USD | -14.88% |
| 2021 Q2 | 799.77 Million USD | -8.47% |
| 2020 FY | 938.65 Million USD | 212.55% |
| 2020 Q2 | 421.68 Million USD | 29.9% |
| 2020 Q3 | 728.8 Million CAD | 72.83% |
| 2020 Q4 | 938.65 Million USD | 28.79% |
| 2020 Q1 | 324.62 Million USD | 8.09% |
| 2019 FY | 300.32 Million CAD | -16.84% |
| 2019 Q3 | 362.1 Million USD | -4.8% |
| 2019 Q2 | 380.37 Million USD | 7.25% |
| 2019 Q4 | 300.32 Million USD | -17.06% |
| 2019 Q1 | 354.66 Million USD | -1.79% |
| 2018 Q1 | 43.07 Million USD | 78.69% |
| 2018 Q2 | 41.54 Million USD | -3.57% |
| 2018 Q4 | 361.11 Million USD | 513.53% |
| 2018 Q3 | 58.85 Million USD | 41.69% |
| 2018 FY | 361.11 Million CAD | 1397.9% |
| 2017 Q3 | 30.26 Million USD | 19.54% |
| 2017 Q2 | 25.31 Million USD | -3.01% |
| 2017 Q1 | 26.1 Million CAD | 5.2% |
| 2017 FY | 24.1 Million CAD | -2.84% |
| 2017 Q4 | 24.1 Million USD | -20.34% |
| 2016 Q4 | 24.81 Million CAD | 272.38% |
| 2016 Q2 | 5.61 Million CAD | -4.8% |
| 2016 Q1 | 5.9 Million CAD | 0.0% |
| 2016 FY | 24.81 Million CAD | 0.0% |
| 2016 Q3 | 6.66 Million CAD | 18.59% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q1 | 120.36 Thousand CAD | 0.0% |
| 2015 Q2 | - CAD | -100.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| MPH Health Care AG | 13.05 Million EUR | -2866.935% |
| Apontis Pharma AG | 6 Million EUR | -6355.283% |
| Dermapharm Holding SE | 1.08 Billion EUR | 64.15% |
| Evotec SE | 626.19 Million EUR | 38.148% |
| MERCK Kommanditgesellschaft auf Aktien | 9.94 Billion EUR | 96.104% |
| PharmaSGP Holding SE | 73.97 Million EUR | -423.564% |
| SynBiotic SE | 3.68 Million EUR | -10424.192% |